Tercica Sues Insmed in U.S. Court
5 Humorous Predictions for Open Source in 2005

Johnson and Johnson says Levaquin patent upheld

LOS ANGELES, Dec 23 (Reuters) - Johnson and Johnson (JNJ.N: Quote, Profile, Research) on Thursday said a U.S. District Court upheld its patent on the antibiotic Levaquin and found that the patent was infringed by generic drugmaker Mylan Laboratories Inc. (MYL.N: Quote, Profile, Research)

Full story.

Please visit our sponsor Gehrke & Associates, SC to learn more about how to enhance and defend your intellectual property.  Thank you.

Comments